NOTIFICATION REGARDING CHANGES IN CARDIOMETABOLIC TESTING

January 18, 2018

We want to inform you of a change in our sample handling procedures for orders requesting Cardiometabolic (CM) testing. This change will be effective 1/29/2018.

We use the test results to assess risk for developing cardiovascular disease and/or type 2 diabetes.  Results are most informative if derived from the same time point.  Beginning on the effective date shown above, if any part of the CM sample is unacceptable for testing, the entire CM order will be rejected and a redraw will be requested.  This process change will ensure that we provide you with the most accurate laboratory data for assessing cardiometabolic risk.

Please contact Customer Support Services at 1-800-227-5227 (option 4) if you have questions.

We appreciate your business and look forward to serving you in the future!

Thank you.
James W. Jacobson, Ph.D.
Vice President and Chief Scientific Officer

NOTIFICATION REGARDING AUTOMATIC ENROLLMENT FOR BORDERLINE REPORTING

June 28, 2016

We want to inform you of a change in our Micronutrient test report. This change will be effective 7/1/2016.

In addition to flagging the test components indicating nutritional deficiencies, we will also be highlighting borderline values – those test components approaching deficiency status that you may find informative in clinical management of your patients.

If you do not want borderline values identified on your patient reports, you may opt out by contacting your SpectraCell sales representative or Customer Support Services at 1-800-227-5227 (option 4).

We appreciate your business and look forward to serving you in the future!

Thank you.